Weight Loss Injections in Nova Scotia: NS Pharmacare & Access Guide

Nova Scotia is home to approximately 1.0 million residents. The province has one of Canada's older population profiles, with a significant proportion of seniors who may benefit from GLP-1 medications for type 2 diabetes management. Nova Scotia Pharmacare provides coverage for seniors and certain low-income residents, while most working-age Nova Scotians rely on private employer benefits.

Nova Scotia at a Glance

Nova Scotia Pharmacare Coverage

Nova Scotia Pharmacare is primarily structured around two programs:

• NS Seniors Pharmacare: For Nova Scotians 65 and older. Provides drug coverage subject to an annual deductible (income-based) and co-pays. Ozempic is listed for type 2 diabetes under this program with appropriate clinical criteria.
• NS Pharmacare for Low-Income Residents: For residents receiving Income Assistance or Disability Support. Provides broader coverage including GLP-1 medications for diabetes.
• NS Pharmacare for Children/Youth: Does not typically apply to GLP-1 medications.

For working-age Nova Scotians who are employed and do not receive social assistance, there is no provincial pharmacare coverage - you rely on employer group benefits or pay out-of-pocket.

Nova Scotia has one of the higher rates of type 2 diabetes in Canada (~10% of adults), partly reflecting older population demographics and lower average incomes. This makes the coverage gap for working-age adults a significant health equity issue in the province.

Wegovy in Nova Scotia

Wegovy is not listed on any Nova Scotia Pharmacare program for weight management. Private insurance or out-of-pocket payment are required. Given that NS Pharmacare for working-age adults is limited, Nova Scotians seeking Wegovy typically rely entirely on private employer benefits.

Private Insurance in Nova Scotia

Private employer drug benefits are the primary coverage pathway for working-age Nova Scotians. Key employers and sectors:

• Nova Scotia Health Authority (NSHA) - the largest employer in the province, healthcare workers have comprehensive benefits
• Provincial government employees - covered under the NS Government collective agreement, typically with good drug benefits
• University and academic sector - Dalhousie, NSCC, and other institutions have group benefits plans
• Small business and self-employed Nova Scotians face the most limited access - GLP-1 costs are entirely out-of-pocket unless they purchase individual health insurance

Getting a Prescription Online in Nova Scotia

Felix Health operates province-wide in Nova Scotia. The complete online assessment, prescription, and home delivery process is available to NS residents. A Nova Scotia-licensed physician reviews your health intake and can prescribe GLP-1 medications for eligible patients.

Cost in Nova Scotia Without Coverage

Without insurance in Nova Scotia, approximate monthly costs as of May 2026:

• Ozempic (0.5–2 mg): ~$230–$415/month
• Wegovy (2.4 mg): ~$400–$430/month
• Mounjaro (5–15 mg): ~$490–$610/month
• Generic semaglutide (expected 2025-26): Estimated $50–$150/month

See the full province-by-province cost guide for more detail.

Nova Scotia FAQ

I'm a working Nova Scotian with no employer benefits. What are my options?

Your main options are: (1) Novo Nordisk Care Rx patient support program - ask your physician or pharmacist about enrollment; (2) Generic semaglutide (Plosbrio/Poviztra), available at 45-90% lower cost than brand-name Ozempic; (3) Individual health insurance through Blue Cross or another insurer. See our generic semaglutide guide.

Is Felix available throughout Nova Scotia?

Yes. Felix Health operates province-wide in Nova Scotia including rural areas, and can arrange delivery to any NS address.